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Susan McClement7, Gary Crow8 and the CIHR/CCMB Team in Primary Care Oncology (PCO-NET)9Abstract
Background: Evaluation of the effectiveness of a patient decision aid (nurse-managed telephone support line and/
or colorectal cancer screening website), distributed to patients by their family physician, in improving fecal occult
blood test (FOBT) colorectal cancer screening rates.
Methods: A pragmatic, two arm, cluster randomized controlled trial in Winnipeg, Manitoba, Canada (39 medical
clinic clusters; 79 fee-for-service family physicians; 2,395 average risk patients). All physicians followed their standard
clinical screening practice. Intervention group physicians provided a fridge magnet to patients that facilitated
patient decision aid access. Primary endpoint was FOBT screening rate within four months.
Multi-level logistic regression to determine effect of cluster, physician, and patient level factors on patient FOBT
completion rate. ICC determined.
Results: Family physicians were randomized to control (n = 39) and intervention (n = 40) groups. Compared to
controls (56.9%; n = 663/1165), patients receiving the intervention had a higher FOBT completion rate (66.6%;
n = 805/1209; OR of 1.47; 95% confidence interval 1.06 to 2.03; p < 0.02). Patient aid utilization was low (1.1%;
13/1,221) and neither internet nor telephone access affected screening rates for the intervention group. FOBT
screening rates differed among clinics and physicians (p < 0.0001). Patients whose physician promoted the FOBT
were more likely to complete it (65%; n = 1140/1755) compared to those whose physician did not (51.1%; n = 242/
470; p < 0.0001; OR of 1.54 and 95% CI of 1.23 to 1.92). Patients reporting they had done an FOBT in the past were
more likely to complete the test (70.6%; n = 1141/1616; p < 0.0001; 95% CI 2.51 to 3.73) than those who had not
(43%; n = 303/705). Patients 50–59 years old had lower screening rates compared to those over 60 (p < 0.0001).
75% of patients completing the test did so in 34 days.
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Conclusion: Despite minimal use of the patient aid, intervention group patients were more likely to complete the
FOBT. Powerful strategies to increase colorectal cancer screening rates include a recommendation to do the test
from the family physician and focusing efforts on patients age 50–59 years to ensure they complete their first FOBT.
Trial registration: Trial registration number: clinicaltrials.gov identifier NCT01026753.
Keywords: Colorectal cancer screening, Fecal occult blood test, Community-based family practice,
Community-based primary healthcare research, Cluster randomized controlled trial, Pragmatic, Patient decision aid,
Integrated knowledge translation, Knowledge exchangeBackground
In Canada, colorectal cancer (CRC) is the third most com-
mon cancer diagnosis and the second most common
cause of death due to cancer (12% of all cancer deaths in
2012) [1]. Prevention and early detection of CRC is pos-
sible through routine fecal occult blood test (FOBT)
screening of individuals 50 to 74 years of age [2,3] as it
has been estimated that if 70% of eligible Canadians com-
pleted an FOBT every two years, followed up by colonos-
copy for positive FOBTs, the CRC mortality rate could be
reduced by 17% [4,5]. Uptake of fecal occult blood test
screening in Canada and Manitoba are sub-optimal. Vari-
ous surveys have indicated rates of self-reported FOBT
uptake for Manitobans of 38% to 64% [6-8]. Improve-
ments in FOBT uptake in those 50 to 59 years of age re-
main warranted based on the estimation that, in 2012, the
highest burden of new cancer diagnoses (28%) and death
(22%) will be in Canadians between the ages 60 to 69 years
of age [1] and only 27.5% of Canadians 50 to 59 years of
age report being screened for CRC [9]. The two most
common reasons Canadians provide for not completing
an FOBT are: (1) they do not see the need for the test and
as they are not experiencing any symptoms (49.3%) of
colorectal cancer and (2) they were not told by their doc-
tor to do the test. Only 38% of Manitobans report having
a discussion about colorectal cancer screening with their
physician [8,9]. Approximately 60% of Manitobans do not
understand that screening begins before symptoms appear
[9]. Seventy-two percent of patients report being up-to-
date with screening after having discussed CRC screening
with their doctors, whereas only 33% of those who did not
have this conversation were up-to-date with CRC screen-
ing [9]. However, physicians estimate it takes approxi-
mately four minutes to do a good job of explaining CRC
and relevant screening options [10] which represents 27
to 40% of the total time for the periodic (annual) health
examination. The complexities of clinical practice, includ-
ing caring for patients with increasingly complex multiple
morbidities [11,12] and time constraints, impact on the
time available to adequately address all health concerns
during the periodic (annual) health examination, especially
prevention and screening [13].Higher FOBT completion rates have been reported in
studies of intervention strategies utilizing one-on-one
patient contact with registered nurses within the medical
clinic. However, this strategy can be costly and time con-
suming [10]. It is also uncommon in most community-
based fee-for-service clinical practices. A multimedia
educational computer program was shown to be as ef-
fective as usual nurse counseling in educating patients
and achieving adherence to FOBT screening [14]. In 2010,
73% of Manitobans had home internet access of which ap-
proximately 75% went online every day in a typical month.
74% percent of females searched for information about
health or medical conditions compared to 66.7% of men
[15]. The role of the internet in supporting positive
health promotion behaviors is currently unknown. Nurse-
managed telephone support for cardiovascular disease pa-
tients has been shown effective in managing the disease
[16]. We postulated that a patient aid, providing colorectal
cancer and screening information that was given to pa-
tients by their family physician, would increase patient
FOBT completion rates. The patient aid was designed to
support family physicians in their goal to increase their
patient’s colorectal cancer screening rates while addressing
the constraints of clinical practice. It contained the URL
address and telephone number for a colorectal cancer
information and screening website and nurse-managed
telephone support line, both specifically designed for
the study.
A systematic review of the literature has reported that
many cluster randomized cancer screening intervention
trials (19 CRC only and 6 CRC plus other sites) had defi-
ciencies in the application of correct statistical proce-
dures for the outcome analysis which led to unjustified
rejection of the null hypothesis [17]. Our study design
accounts for the complexities of cluster randomization
at both the clinic and family physician levels and is able
to contribute intraclass correlation coefficients for these
outcome variables.
Methods
Community-based fee-for-service family physicians (FP)
were recruited within the city of Winnipeg, Manitoba,
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matic cluster randomized controlled trial. In order to be
eligible for the study, FPs had to be in full or part-time
regular solo or group family practice. Some participating
physicians were involved in local primary care quality im-
provement initiatives (Uniting Primary Care and Oncology
and Physician Integrated Network) [18,19] that could im-
pact CRC screening rates, therefore this was addressed in
our analyses. Each physician’s patients were eligible for
participation in the study if they were 50 to 74 years of
age, had no symptoms of CRC, no personal history of
CRC, polyps or diseases of the colon requiring monitoring
by colonoscopy (Crohn’s Disease or Ulcerative Colitis). Pa-
tient consent was obtained by the physician’s support staff.
All of a physician’s patients received the same experimen-
tal treatment (control or intervention) based on the cluster
randomization. Hence, patient consent was obtained post
randomization. The study protocol was approved by the
University of Manitoba Health Research Ethics Board.
Randomization of clusters was conducted by a biostatis-
tician using a computer-generated list. Clusters were block
randomized based on the number of collaborating FPs
within a practice. An absolute increase in FOBT screening
rates of 15% from the most current FOBT completion rate
know at the time of the study (42% in Manitoba) was con-
sidered clinically significant [15]. Sample size was deter-
mined by a biostatistician using PASS (Power and Sample
Size, 2002) software [19] and a computer simulated ICC
value of 0.6 [20]; a very conservative estimate of the mini-
mum detectable effect size given the proposed sample size.
Based on logistic regression, a cluster size of 41 clusters
each enrolling 30 to 35 patients (1230 observations) will
achieve 90% power at a 0.05 significance level to detect a
change from the baseline value of 0.400 to 0.550 and cor-
responds to an odds ratio of 1.833. In the event that family
physician collaboration/retention and/or patient recruit-
ment proved to be more difficult than anticipated, a logis-
tic regression with a cluster size of 28 (840 observations)
would have achieved 80% power with the same outcomes.
All FPs collaborating in the study followed their usual
clinical practice for CRC screening with the FOBT during
the patient periodic (annual) health examination. The ra-
tionale for not customizing this portion of the study was
to optimize FP collaboration and to simulate “real world”
clinical practice. The study coordinator (KC) enrolled
family physicians/clusters and family physicians enrolled
patients. The intervention was applied at the medical
clinic (cluster) level; each cluster was randomized to either
the control or intervention group. The randomization se-
quence was concealed until interventions were assigned
by the study coordinator. Patients, as well as those asses-
sing the outcomes, were blinded to treatment group desig-
nation. FPs in the intervention group provided their
patients with the patient aid (refrigerator magnet) duringthe physician visit. This magnet provided information on
how to access a study specific colorectal cancer informa-
tion and screening nurse-managed telephone support line
(telephone number) and website (URL). Access to the
telephone support line and/or website for the interven-
tion group was patient initiated and was tracked with
the assigned study-specific, identification number.
Factors influencing FOBT completion rate were assessed
at three levels: medical clinic cluster, individual family
physician, and patient. Patient aid utilization was also eval-
uated. Data were obtained from three study specific sur-
veys: the In-Clinic Patient Survey (completed prior to the
visit by all patients of each FP), Post-Study Patient Follow-
Up telephone survey (n = 10 patients per family physician
in both treatment groups), and Family Physician Surveys
(provided to all FPs involved in the study. Time to com-
pletion of the FOBT is a secondary outcome variable re-
ported along with relevant family physician and patient
post-study survey responses. Further details regarding the
study methods can be found in the published protocol
paper [21].
The primary dependent variable was the binary response
of patients completing the FOBT within four months.
However, patients were eligible to complete the FOBT test
after the four month end-point as this was an arbitrary
cut-off point based on the literature suggesting most pa-
tients complete the FOBT within four to six weeks of
receiving the test [10]. This information was obtained by
the study coordinator (KC) directly from each family
physician. Factors affecting FOBT uptake included patient
characteristics as well as those of the physician and clinic.
The trial protocol [19] defines a multi-level investigation
facilitating analysis of the intraclass correlation coefficient
(ICC) for each primary group-level outcome (medical
cluster, family physician, and patients) [22]. A number of
statistical models were used to test hypotheses about
factors and their interactions. Most models were mixed
models with factors such as age, gender, socioeconomic
status (SES), use of an electronic medical record (EMR),
and practice participation in primary care reform initia-
tives considered as fixed effects. Clinic and physician were
considered to be random effects and to be representative
of the population of physicians and the clinics to which
they belonged. The GLIMMIX procedure of SAS 9.2 was
used for this analysis; factors and their interactions were
considered significant using a type I error rate of 0.05.
Results
Community-based fee-for-service family physicians were re-
cruited over eight months (January, 2010 to August, 2010).
Study implementation occurred between September and
October 2010 and was completed July 2011. Family phys-
ician recruitment rate was 79.44% (85/107). Community-
based family physicians (n = 79) from 22 medical clinics
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2,395 patients. Figure 1 outlines the CONSORT flow dia-
gram for the study. Tables 1, 2 and 3 outline the baseline
characteristics for each treatment group for control and
intervention clusters, family physicians and patients, re-
spectively. All analyses were based on the intention to
treat model.
The control group was composed of 19 clusters, 39
community-based family physicians and 1,174 patients.Figure 1 CONSORT flow diagram for family physician recruitment5. 1R
medical clinics (of which 3 contained both control and intervention cluster
number of patients was n = 2,395; 915 males, 1473 females. 3Control group
represented by 12 clinics and 20 clusters. See Table 5 for detailed descripti
intervention (n = 1,221). 5Based on the CONSORT flow diagram [23].The intervention group was composed of 20 clusters
representing 40 community-based family physicians and
1, 221 patients. Family physicians from both groups had
similar levels of utilization of electronic medical records
(64.1% and 62.5%) and on-site laboratories (92.3% and
97.5%). In addition, the percentage of family physicians
in the control and intervention groups who were part of
a solo and group clinical practice were similar (92.3%
and 97.5%, respectively for group practice). Membershipepresenting 30 community-based medical clinics. 2Representing 23
s). Each family physician was asked to enroll 30–35 patients. Total
represented by 13 clinics and 19 clusters; intervention group
on of clusters. 4Number of patients analyzed; control (n = 1,174) and
Table 1 Baseline characteristics of clusters and physicians randomized to the control and intervention groups1,2,3
Control
Cluster No. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 -









































No. of Patients 145 31 23 72 33 16 245 67 22 90 34 36 40 67 28 30 100 27 36 -




Y N N Y Y N Y N N Y N N Y Y Y Y Y Y N -
Electronic Medical Record Y N Y Y Y N Y N N Y Y N N Y Y N N N N -
Intervention
Cluster No. 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39










































No. of Patients 54 10 32 32 20 96 129 5 92 92 30 32 64 61 20 93 29 178 31 99
No. of Patients Utilizing the
Patient Aid
(Website; Telephone) 4 - - - - 1 1 - 2 4 1 2 1 - - 1 2 3 - 4
Cluster Screening Rate (%) 71 64 66 55 45 62 76 20 64 70 77 79 70 61 80 59 64 63 63 74
Membership in Primary Care
Quality Improvement Initiative
N Y Y N N N N N N N Y Y N N Y N Y Y Y Y
Electronic Medical Record Y Y N N N Y Y N N N N N Y N N Y N Y Y Y
1Control treatment group composed of n = 19 clusters, n = 40 family physicians and n = 1,174 patients). Intervention treatment group composed of n = 20 clusters,
n = 41 family physicians and n = 1,221 patients.
2Average FOBT screening rate = 57% (range: 33.8 to 81.5%) compared to 66.6% (range: 20 to 78.8%) for the intervention group (p < 0.0001). Figures 2 and 3 show
the screening rates for the control and intervention group clusters and family physicians, respectively.
3Yes = Y, and No = N.






















































1Percentage of male and female family physicians in each treatment group involved in a primary care quality improvement initiatives (PIN, UPCON, or PIN +
UPCON). 77% of family physicians in the control group were involved in a primary care quality improvement initiative, compared to 40% of family physicians in
the intervention group. Table 4 outlines the number of patient in each treatment group according to the primary care quality improvement initiatives.
2Four (5.1%) of the collaborating physicians were in solo practice; two males in the control group and one male in the intervention group.
3Four (5.1%) of physicians did not have an on-site laboratory; three males in the control group and one male in the intervention group.
450 of 79 family physicians (63.3%) were using electronic medical records.
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Table 3 Baseline characteristics of patients enrolled in








Male (%) 438 (37.3) 468 (38.3)
Female (%) 736 (62.7) 753 (61.7)
Age in years (total)1
50-54 119/194 (313) 124/209 (333)
55-59 99/164 (263) 123/193 (318)
60-64 109/156 (265) 100/163 (268)
65-69 65/123 (188) 70/100 (172)
≥70 46/89 (135) 51/72 (124)
Socioeconomic Status (SES)2
Rural-1 102 (8.7%) 157 (12.9%)
Urban-1 90 (7.7%) 82 (6.7%)
Urban-2 324 (27.6%) 316 (25.9%)
Urban-3 600 (51.1%) 603 (49.4%)
Unknown 58 (4.9%) 63 (5.2%)
Membership in PIN and/or UPCON
PIN 419 (35.7%) 314 (25.7%)
UPCON 482 (41.1%) 159 (13%)
None 274 (23.3%) 747 (61.2%)
Electronic Medical Records
No 451 (38.4%) 452 (37.0%)
Yes 724 (61.6%) 768 (63.0%)
1Males/Females; bracketed values represent totals.
2Source: Manitoba Centre for Health Policy, 2010. Based on postal codes. Rural
($22,449 to 148,242); Urban-1 ($14,640 to 42,407); Urban-2 ($42,463 to 68,132);
Urban-3 ($68,140 to 406,531). Bracketed values correspond to percentages.
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did not represent a factor in determining differences in
FOBT completion rates.
Of the patients participating in the study, approxi-
mately 60% were female and 40% male in both groups.
Patient age distribution was also similar in the treatment
groups.
Table 4 outlines the effect of cluster, physician, and pa-
tient level factors on patient FOBT completion rate de-
termined by multi-level logistic regression. Patients in
the intervention group had a significantly higher FOBT
completion rate (66.6%; n = 805/1209; odds ratio 1.47
with 95% CI 1.06 to 2.03, p < 0.02) compared to those in
the control group (56.9%; n = 663/1165). The interclass
correlation coefficients were 0.003, 0.009, and 0.217 for
the primary group level outcomes of cluster, family phys-
ician, and patient.
Utilization of the patient tools was 13/1,221 (1.07%)
for both the website and the nurse-managed telephonesupport line representing 16 family physicians from 12
clusters. Four males (average age 65 years) and 9 females
(average age 61 years) accessed the website and 10/13
(76.9%) completed their FOBT. Four males (average age
70 years) and nine females (average age 57 years) called
the telephone support line and 8/13 (61.5%) completed
their FOBT. Table 5 outlines the FOBT completion rate
by treatment, gender and age.
Although FOBT completion rate was not affected by
patient gender or socioeconomic status, there was a sig-
nificant increase in FOBT completion rate as individuals
aged (p < 0.0001). There were also significant differences
in FOBT screening rates among clusters within the same
treatment group (Figures 2 and 3; p < 0.0001) as well as
between treatment groups (p < 0.0001). Similarly, there
were significant differences in FOBT screening rates among
family physicians within the same cluster and treatment
group (p < 0.0001) as well as between treatment groups
(p < 0.0001).
Table 6 outlines Patient and Family Physician Follow-
Up Survey responses. Fifty-one percent (n = 242/470) of
patients whose physician did not suggest the FOBT com-
pleted the test. Patients whose physician suggested the
FOBT were significantly more likely to complete the test
(65%; n = 1140/1755, 95% CI 1.23 to 1.92; p < 0.0001).
Compared to patients reporting they had never completed
an FOBT in the past (43%; n = 303/705), patients report-
ing they had were more likely to complete the FOBT
(70.6%; n = 1141/1616; 95% CI 2.51 to 3.73; p < 0.0001).
Patients in the intervention group reported a significantly
higher level (40.2%; 149/371) of discussion about the im-
portance of doing the FOBT compared to the control
group (27.6%; 102/369; p < 0.01). However, family physi-
cians in the intervention group (Family Physician Survey)
reported that their patients did not ask more questions
than usual about CRC, CRC screening, or the FOBT.
This study found that patients reporting on the pres-
ence of a computer in their home were similar for both
the control and intervention groups (90.8%, n = 325/358,
of control group patients compared to 87.7%, n = 321/
366, in the intervention group) as well as self -reported
internet use to answer health related questions.
For those study participants from both the control and
intervention groups who completed their FOBT, 25% did
so within six days, 50% within 14 days, 75% within 34 days,
and 95% within 178 days.
Discussion and conclusion
A patient aid (refrigerator magnet), promoting a study
specific website and nurse-managed telephone line that
supplied colorectal cancer screening information, was
distributed to patients by their family physician with the
goal of increasing colorectal screening rates. The inter-
vention group showed significantly higher fecal occult









Control 56.9 - - -
Intervention 66.6 1.47 1.06, 2.03 0.0001
Patient Gender
Female 61.6 - - -
Male 62.1 1.07 0.88, 1.29 NS
Patient Age (years)
50 to 54 51.3 - - -
55 to 59 60.8 1.38 1.09, 1.74 0.0001
60 to 64 65.1 1.76 1.38, 2.25 0.0001
65 to 69 70.4 2.33 1.75, 3.10 0.0001
70 to 74 72.2 2.43 1.75, 3.37 0.0001
Have you ever done an FOBT before?4
No 43.0 - - -
Yes 70.6 3.06 2.51, 3.73 0.0001
Has a healthcare provider ever suggested you do an FOBT?4
No 51.5 - - -
Yes 65.0 1.54 1.23, 1.92* 0.0001
Unsure 51.5 1.17 0.80, 1.74 NS
1The Intraclass Correlation Coefficients (ICC) for the medical clinic cluster, family physician, and patient level variables were 0.003, 0.009, and 0.217, respectively.
2The bolded percentages denote significant differences for each factor.
3NS = not statistically significant.
4These factors were obtained from the (pre-visit) In-Clinic Patient Survey [18]. There were significant interactions between each factor and cluster (p < 0.0001) as
well as family physician (p < 0.0001).
*Determined by multi-level logistic regression. FOBT completion rate frequency converted from logit scale for the factor treatment are 0.61for the control and
0.69 for intervention groups (p < 0.02); for the factor patient gender are 0.65 and 0.66 for control and intervention groups, respectively (NS); For patient age are
0.53, 0.60, 0.66, 0.73 and 0.72 for the age categories 50 to 54, 55 to 59, 60 to 64, 65 to 69, and 70 to 74, respectively (p < 0.0001); for the survey question “Have
you ever done an FOBT before” are 0.48 and 0.73 for the answer ‘no’ and ‘yes’, respectively (p < 0.0001); for the survey question “Has a healthcare provider ever
suggested you do an FOBT” are 0.58, 0.68 and 0.62 for the answer ‘no’, ‘yes’ and unsure, respectively (p < 0.0001 for yes and NS for unsure).
Table 5 Fecal occult blood test completion by treatment, gender, and age category
Fecal occult blood test status1,2,3
Control group4 Intervention group5 TOTAL
Male Female Male Female
Age group No Yes (%) No Yes (%) No Yes (%) No Yes (%) No Yes (%)
50 to 54 69 50 (42.0) 107 87 (44.9) 45 79 (63.7) 95 114 (54.6) 316 330 (51.1)
55 to 59 43 56 (56.6) 76 88 (53.7) 44 79 (64.2) 64 129 (66.8) 227 352 (60.8)
60 to 64 49 60 (55.1) 57 99 (63.5) 27 73 (73.0) 51 112 (68.7) 184 344 (65.2)
65 to 70 20 45 (69.2) 39 84 (68.3) 14 56 (80.0) 33 67 (67.0) 106 252 (70.4)
70+ 14 32 (69.6) 27 62 (69.7) 18 33 (64.7) 13 59 (81.9) 72 186 (72.1)
TOTAL 195 243 (55.5) 306 420 (57.9) 148 320 (68.4) 256 481 (65.3) 905 1464 (61.8)
1Significant effect of treatment (p < 0.0001) and age (p < 0.0001); no gender or socioeconomic status effects (data not shown).
2Values represent number of patients with incomplete FOBT (No) and complete FOBT (Yes) status for males and females in the control and intervention
treatment groups.
3Bracketed values represent the percentage of patients with complete FOBT status.
4Number of missing values due to unknown age or gender was 4 males and 5 females for control group.
5Number of missing values due to unknown age or gender was 6 males and 5 females for the intervention group.
Clouston et al. BMC Cancer 2014, 14:263 Page 7 of 11
http://www.biomedcentral.com/1471-2407/14/263
Figure 2 Screening rate for individual family physicians in the control group by gender and cluster. There were significant differences in
FOBT screening rates among the clusters in the control group (p < 0.0001). Average screening rate for control group is 57%; range 33.8 to 81.5%.
F = Female, M = Male. See text for further details.
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This study demonstrates a feasible and effective method
of incorporating primary healthcare research into
community-based fee-for-service family practice to pro-
duce clinically relevant findings.
As a pragmatic trial, this study had very broad inclusion
criteria (age and eligibility for CRC screening) representa-
tive of the “typical” patient seen by family physicians in
daily clinical practice, with little (if any) intervention in the
routine physician-patient interaction. Hence, the findings
should be generalizable to community-based family prac-
tice and, therefore provide meaningful and relevant impli-
cations for clinical family practice. Earlier self-reported
estimates of CRC screening rates in Manitoba were be-
tween 38 to 42% [7,9] with a more recent self-reported
provincial screening rate of 64% [8]. However, both sur-
veys combined FOBT, colonoscopy and flexible sigmoid-
oscopy in the definition of colorectal cancer screening.
Hence, we are unable to compare the screening rates
found in the study to those in the surveys to determine
whether the control group rates are indicative of ‘typical’
rates or whether this group experienced an interventionFigure 3 Screening rate for individual family physicians in the interve
differences in FOBT screening rates among the clusters in the intervention
66.6%; range 20 to 78.8%. F = Female, M =Male. See text for further details.effect along with the intervention group. Patients in
the intervention group did, however, have a significantly
higher FOBT completion rate than those in the control
group. This may be due to physicians being reminded to
have a conversation about the importance of CRC screen-
ing with their patients through their role in handing out
the study intervention magnet, despite the self-report that
this was not the case. Previous research supports the ap-
parent lack of veracity of physician responses to questions
of this nature [24,25]. The striking findings of this study
are the very low rates of utilization of the information re-
sources provided. Neither internet nor telephone access
were an issue for the intervention group. Instead, direct
communication from the family physician underscoring
the importance of screening seems to have obviated the
need for access to the educational materials. The mere
provision of the patient aid, by a family physician to their
patient, may have underscored importance of, and the
physician’s recommendation to do the test. If this is the
case, it is clear evidence of the value of family physicians
in promoting CRC screening. It also provides a simple and
effective method for family physicians to improve patientntion group by gender and cluster. There were significant
group (p < 0.0001). Average screening rate for intervention group is
Table 6 Patient and family physician reported colorectal cancer screening and fecal occult blood testcommunications1
Study treatment group2,3
Control n = 334 (%) Intervention n = 351 (%) p value
Patient Reported Family Physician Communication
Did anyone talk to you about CRC during your appointment? 103 (27.7) 153 (40.1) 0.01
Did anyone tell you why it’s important to do the FOBT? 188 (50.8) 228 (59.7) NS
Did you get instructions about how to do the FOBT? 244 (67.2) 277 (73.5) NS
Any questions about the test that were not explained? 9 (2.5) 8 (2.1) NS
Family Physician Reported Communication
The study protocol caused my patients to ask more questions than usual about: Control (n = 33) Intervention (n = 36) p Value
Colorectal Cancer 16 (57.1) 12 (42.9) NS
Colorectal Cancer Screening 18 (56.3) 14 (43.8) NS
Fecal occult blood test 19 (61.3) 12 (38.7) NS
1Survey details can be found in the study protocol [18]; 10 patients from each family physician responded to the Post-Study Patient Survey.
2Values represent the number of patients or family physicians responding “Yes” to each question.
3Response rate to the patient and physician surveys were 66.7% (685/1142) and 87.3% (69/79 family physicians, respectively).
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constraints a clinician has to address all other health issues
during the physical exam. A future question for investiga-
tion based on the study findings is whether physicians
must provide a patient aid to their patients (such as the
magnet in this study), or whether it is possible to use an
even simpler strategy?
Findings from the multi-level regression analysis dem-
onstrate that the most significant factors affecting CRC
screening rate are family physician-patient communica-
tion and patient level factors. The Post-Study Patient
Follow-Up Survey showed that a significantly higher num-
ber of patients in the intervention group (40.0% versus
27.7%) reported that someone had talked to them about
CRC during their clinic visit. A systematic review con-
ducted in 2010 demonstrated that there is high quality
evidence supporting one-on-one interactions in increasing
absolute CRC screening rates (between 15 to 42 percent)
and provided strong evidence to support the effectiveness
of patient reminders in increasing absolute CRC screening
rates (5 to 15%) [26]. It is possible that for some patients
in the intervention group of this study, the magnet func-
tioned as both a personal recommendation from their
health care provider and a reminder to undergo CRC
screening. An important finding of this study is that a
much more practical and clinically relevant method may
exist for the one-on-one interaction required by a family
physician to convey the importance of CRC screening to
their patient’s. In fact, our findings suggest a very brief
show of support of the FOBT is necessary compared to
the increased time reported in the literature necessary to
increase CRC screening rates [10].
The implications of our findings for clinical practice
suggest family physicians specifically focus their efforts
to support CRC screening behavior on men and women
between the ages 50 to 60 years, which represent thegroup with the lowest screening rates and the most
benefit to gain from screening. If supporting uptake of
FOBT screening is successful for this age group of men
and women, our findings show that these individuals are
much more likely to engage in repeat screening. Hence,
the possible outcome is reduction in incidence and mor-
tality from CRC in the age group most highly burdened
by the disease (60 to 69 years of age) [7]. Our results
confirm those reported in that FOBT uptake tends to in-
crease with age among men and women [27].
There are a few limitations of the study. Inclusion of the
In-Clinic Patient Survey in both study groups may have
raised patient awareness about CRC and screening suffi-
ciently to affect/improve screening rates in the control
group. In addition, those family physicians agreeing to
participate in the study may have done so with awareness
that their patients have a relatively higher screening rate.
The results may be limited to fee-for-service family physi-
cians and those in urban areas. Some providers were in-
volved in quality improvement interventions (PIN and
UPCON) [18,28]. These clinics may have a specific ap-
proach to screening that has already lead to improvements
in patient CRC screening rates and functioning/practice
may be more evidence-based compared to those that are
not involved in these initiatives. In these groups, the study
intervention may have minimal effect. There was uneven
distribution of physicians with no membership in PIN or
UPCON in the control (n = 9) and intervention (n = 24)
groups. However, the multi-level regression analysis failed
to demonstrate a relationship between participation in ei-
ther initiative and treatment effect on FOBT status.
The study design is unique in that intraclass correlation
coefficients (ICC) values for colorectal cancer screening
rates are provided for three levels of clustering: at three
levels; the patient, family physician and medical clinic. To
our knowledge, this is the first paper to present ICCs for
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This is a beneficial contribution to the scientific literature
by supporting future appropriate design and analysis of
primary prevention trials. For FOBT completion rate, the
ICCs were small (0.003 and 0.009 for medical clinics and
family physicians, respectively) and the design effects (1.12
and 1.02 for medical clinic and family physician, respect-
ively) would result in a power calculation very similar to
that of a simple randomized trial. The low ICCs demon-
strate the minimal extent to which patient FOBT screen-
ing rate was influenced by clustering of observations in
higher level groups (family physician and medical clinic/
cluster). The findings demonstrate that FOBT screening
status is influenced most strongly by factors at the level of
the patient, whereas the family physician and clinic (cluster)
and factors have less of an impact on FOBT screening rates.
As the number of primary care prevention trials are
increasing, future study protocols will increasing rely on
cluster randomized designs. Reporting of intraclass cor-
relation coefficients is necessary to accurately calculate
sample size at the level of community-based primary care
practice. This paper adds to the literature by providing
intraclass correlation coefficients for colorectal cancer
screening rates at the primary care practice level (medical
clinic, family physician, and patient) that will assist in fu-
ture design and analysis of appropriate clustered primary
prevention trials.
Our results provide family physicians a clinically rele-
vant practice tool that is responsive to the requirements
of daily clinical practice and both feasible and effective
in increasing colorectal cancer screening rates among
their patients.
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